Showing results (41-50 of 249) with videos related to

Sort By:
Pageof 25
Trends in Molecular Medicine|September 11, 2009
Mechanisms of bone repair and regenerationFrédéric Deschaseaux, Luc Sensébé, Dominique Heymann
Expert Review of Anticancer Therapy|February 19, 2008
Liposomal muramyl tripeptide phosphatidyl ethanolamine: a safe and effective agent against osteosarcoma pulmonary metastasesKanji Mori, Kosei Ando, Dominique Heymann
Cytokine & Growth Factor Reviews|December 19, 2002
Recent advances in TGF-beta effects on chondrocyte metabolism. Potential therapeutic roles of TGF-beta in cartilage disordersEva Grimaud, Dominique Heymann, Françoise Rédini
Journal of Clinical Medicine|November 10, 2016
TGF-β Signaling in Bone Remodeling and Osteosarcoma ProgressionAudrey Lamora, Julie Talbot, Mathilde Mullard, et al.
Bone|July 6, 2020
Bisphosphonates in common pediatric and adult bone sarcomasMarie-Francoise Heymann, Frederic Lezot, Dominique Heymann
Cellular Immunology|November 10, 2017
The contribution of immune infiltrates and the local microenvironment in the pathogenesis of osteosarcomaMarie-Françoise Heymann, Frédéric Lézot, Dominique Heymann
British Journal of Pharmacology|January 25, 2020
Bone sarcomas in the immunotherapy eraMarie-Françoise Heymann, Kristina Schiavone, Dominique Heymann
Cancer Letters|November 30, 2016
Cancer stem cells in osteosarcomaHannah K Brown, Marta Tellez-Gabriel, Dominique Heymann
International Journal of Cancer|March 30, 2006
Zoledronic acid slows down rat primary chondrosarcoma development, recurrent tumor progression after intralesional curretage and increases overall survivalFrançois Gouin, Benjamin Ory, François Rédini, et al.
Current Medicinal Chemistry|June 23, 2007
mTOR inhibitors (rapamycin and its derivatives) and nitrogen containing bisphosphonates: bi-functional compounds for the treatment of bone tumoursBenjamin Ory, Gatien Moriceau, Francoise Redini, et al.
Pageof 25